{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:57:20Z","timestamp":1787061440435,"version":"build-2736575974"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12325-025-03399-x","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:12:47Z","timestamp":1761117167000},"page":"6209-6233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mental Health Experiences and Challenges Among Individuals with Myasthenia Gravis: Insights from Patient-Centered, Qualitative Analyses"],"prefix":"10.1007","volume":"42","author":[{"given":"Rachelle D.","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley E. L.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly G.","family":"Gwathmey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline R.","family":"Brethenoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghav","family":"Govindarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar","family":"Souayah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley D.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis A.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zia U.","family":"Choudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"issue":"1","key":"3399_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-019-0079-y","volume":"5","author":"NE Gilhus","year":"2019","unstructured":"Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, Verschuuren JJGM. Myasthenia gravis. Nat Rev Dis Primers. 2019;5(1):1\u201319.","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"3399_CR2","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1136\/jnnp.52.10.1121","volume":"52","author":"HJ Oosterhuis","year":"1989","unstructured":"Oosterhuis HJ. The natural course of myasthenia gravis: a long term follow up study. J Neurol Neurosurg Psychiatry. 1989;52(10):1121\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"3399_CR3","doi-asserted-by":"publisher","first-page":"6597","DOI":"10.1007\/s00415-022-11316-3","volume":"269","author":"A Gu\u00e9guen","year":"2022","unstructured":"Gu\u00e9guen A, Hijazi B, Zuber K, Deschamps R, Lamirel C, Vignal-Clermont C, et al. Generalization of ocular myasthenia gravis 10 years after onset. J Neurol. 2022;269(12):6597\u2013604.","journal-title":"J Neurol"},{"key":"3399_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ajo.2019.04.017","volume":"205","author":"TM Hendricks","year":"2019","unstructured":"Hendricks TM, Bhatti MT, Hodge DO, Chen JJ. Incidence, epidemiology, and transformation of ocular myasthenia gravis: a population-based study. Am J Ophthalmol. 2019;205:99\u2013105.","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"3399_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112235","volume":"10","author":"L Dresser","year":"2021","unstructured":"Dresser L, Wlodarski R, Rezania K, Soliven B. Myasthenia gravis: Epidemiology, pathophysiology and clinical manifestations. J Clin Med. 2021;10(11):2235.","journal-title":"J Clin Med"},{"key":"3399_CR6","doi-asserted-by":"publisher","first-page":"1177249","DOI":"10.3389\/fimmu.2023.1177249","volume":"14","author":"Z Bi","year":"2023","unstructured":"Bi Z, Zhan J, Zhang Q, Gao H, Yang M, Ge H, et al. Clinical and immune-related factors associated with exacerbation in adults with well-controlled generalized myasthenia gravis. Front Immunol. 2023;14:1177249.","journal-title":"Front Immunol"},{"issue":"1","key":"3399_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12883-022-02692-4","volume":"22","author":"L Harris","year":"2022","unstructured":"Harris L, Graham S, MacLachlan S, Exuzides A, Jacob S. A retrospective longitudinal cohort study of the clinical burden in myasthenia gravis. BMC Neurol. 2022;22(1):172.","journal-title":"BMC Neurol"},{"key":"3399_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11061597","author":"MK Alhaidar","year":"2022","unstructured":"Alhaidar MK, Abumurad S, Soliven B, Rezania K. Current treatment of myasthenia gravis. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11061597.","journal-title":"J Clin Med"},{"issue":"4","key":"3399_CR9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/CND.0000000000000257","volume":"20","author":"AN Boscoe","year":"2019","unstructured":"Boscoe AN, Xin H, L\u02bcItalien GJ, Harris LA, Cutter GR. Impact of refractory myasthenia gravis on health-related quality of life. J Clin Neuromuscul Dis. 2019;20(4):173\u201381.","journal-title":"J Clin Neuromuscul Dis"},{"issue":"6","key":"3399_CR10","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1007\/s00415-021-10891-1","volume":"269","author":"S Lehnerer","year":"2022","unstructured":"Lehnerer S, Jacobi J, Schilling R, Grittner U, Marbin D, Gerischer L, et al. Burden of disease in myasthenia gravis: taking the patient\u2019s perspective. J Neurol. 2022;269(6):3050\u201363.","journal-title":"J Neurol"},{"issue":"1","key":"3399_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13023-023-02727-0","volume":"18","author":"M Mahic","year":"2023","unstructured":"Mahic M, Bozorg A, DeCourcy J, Golden K, Gibson G, Taylor C, et al. Physician- and patient-reported perspectives on myasthenia gravis in Europe: a real-world survey. Orphanet J Rare Dis. 2023;18(1):169.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3399_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2840","volume":"13","author":"J Nadali","year":"2023","unstructured":"Nadali J, Ghavampour N, Beiranvand F, Maleki Takhtegahi M, Heidari ME, Salarvand S, et al. Prevalence of depression and anxiety among myasthenia gravis (MG) patients: a systematic review and meta-analysis. Brain Behav. 2023;13(1):e2840.","journal-title":"Brain Behav"},{"issue":"1","key":"3399_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-066445","volume":"13","author":"S Dewilde","year":"2023","unstructured":"Dewilde S, Philips G, Paci S, Beauchamp J, Chiroli S, Quinn C, et al. Patient-reported burden of myasthenia gravis: baseline results of the international prospective, observational, longitudinal real-world digital study MyRealWorld-MG. BMJ Open. 2023;13(1):e066445.","journal-title":"BMJ Open"},{"key":"3399_CR14","unstructured":"World Health Organization. Global health estimates: Depression and other common mental disorders. 2017. Available from: https:\/\/www.who.int\/publications\/i\/item\/depression-global-health-estimates"},{"key":"3399_CR15","unstructured":"Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the 2022 national survey on drug use and health. 2023. Available from: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt42731\/2022-nsduh-nnr.pdf"},{"issue":"1","key":"3399_CR16","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1186\/s12967-021-03185-7","volume":"19","author":"N Salari","year":"2021","unstructured":"Salari N, Fatahi B, Bartina Y, Kazeminia M, Fatahian R, Mohammadi P, et al. Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis. J Transl Med. 2021;19(1):516.","journal-title":"J Transl Med"},{"issue":"2","key":"3399_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000529583","volume":"57","author":"H Wartmann","year":"2023","unstructured":"Wartmann H, Hoffmann S, Ruck T, Nelke C, Deiters B, Volmer T. Incidence, prevalence, hospitalization rates, and treatment patterns in myasthenia gravis: a 10-year real-world data analysis of German claims data. Neuroepidemiology. 2023;57(2):121\u20138.","journal-title":"Neuroepidemiology"},{"key":"3399_CR18","doi-asserted-by":"crossref","unstructured":"Rodrigues E, Umeh E, Aishwarya, Navaratnarajah N, Cole A, Moy K. Incidence and prevalence of myasthenia gravis in the United States: a claims-based analysis. Muscle Nerve. 2024;69(2):166\u201371.","DOI":"10.1002\/mus.28006"},{"key":"3399_CR19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jpsychires.2019.08.002","volume":"126","author":"Q Liu","year":"2020","unstructured":"Liu Q, He H, Yang J, Feng X, Zhao F, Lyu J. Changes in the global burden of depression from 1990 to 2017: findings from the Global Burden of Disease study. J Psychiatr Res. 2020;126:134\u201340.","journal-title":"J Psychiatr Res"},{"key":"3399_CR20","doi-asserted-by":"publisher","DOI":"10.2196\/49609","volume":"10","author":"H Cao","year":"2024","unstructured":"Cao H, Wu Y, Yin H, Sun Y, Yuan H, Tao M. Global trends in the incidence of anxiety disorders from 1990 to 2019: joinpoint and age-period-cohort analysis study. JMIR Public Health Surveill. 2024;10:e49609.","journal-title":"JMIR Public Health Surveill"},{"issue":"2","key":"3399_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/070674379904400205","volume":"44","author":"SB Patten","year":"1999","unstructured":"Patten SB. Long-term medical conditions and major depression in the Canadian population. Can J Psychiatry. 1999;44(2):151\u20137.","journal-title":"Can J Psychiatry"},{"issue":"2","key":"3399_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/070674370204700204","volume":"47","author":"LM Gagnon","year":"2002","unstructured":"Gagnon LM, Patten SB. Major depression and its association with long-term medical conditions. Can J Psychiatry. 2002;47(2):149\u201352.","journal-title":"Can J Psychiatry"},{"issue":"4","key":"3399_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/070674370505000402","volume":"50","author":"SB Patten","year":"2005","unstructured":"Patten SB, Beck CA, Kassam A, Williams JV, Barbui C, Metz LM. Long-term medical conditions and major depression: strength of association for specific conditions in the general population. Can J Psychiatry. 2005;50(4):195\u2013202.","journal-title":"Can J Psychiatry"},{"issue":"1\u20133","key":"3399_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jad.2007.01.015","volume":"103","author":"KM Scott","year":"2007","unstructured":"Scott KM, Bruffaerts R, Tsang A, Ormel J, Alonso J, Angermeyer MC, et al. Depression-anxiety relationships with chronic physical conditions: results from the World Mental Health Surveys. J Affect Disord. 2007;103(1\u20133):113\u201320.","journal-title":"J Affect Disord"},{"issue":"3","key":"3399_CR25","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1080\/08870446.2018.1541989","volume":"34","author":"E Butler","year":"2019","unstructured":"Butler E, Thomas R, Carolan A, Silber E, Chalder T. \u201cIt\u2019s the unknown\u201d - understanding anxiety: from the perspective of people with multiple sclerosis. Psychol Health. 2019;34(3):368\u201383.","journal-title":"Psychol Health"},{"issue":"9","key":"3399_CR26","first-page":"5513","volume":"29","author":"HM Fisher","year":"2021","unstructured":"Fisher HM, Winger JG, Miller SN, Wright AN, Plumb Vilardaga JC, Majestic C, et al. Relationship between social support, physical symptoms, and depression in women with breast cancer and pain. Support Care Cancer. 2021;29(9):5513\u201321.","journal-title":"Support Care Cancer"},{"key":"3399_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1477-7525-6-13","volume":"6","author":"SD Mathias","year":"2008","unstructured":"Mathias SD, Gao SK, Miller KL, Cella D, Snyder C, Turner R, et al. Impact of chronic immune thrombocytopenic purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective. Health Qual Life Outcomes. 2008;6:13.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"3399_CR28","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1080\/07853890.2022.2105394","volume":"54","author":"T Tang","year":"2022","unstructured":"Tang T, Li Z, Lu X, Du J. Development and validation of a risk prediction model for anxiety or depression among patients with chronic obstructive pulmonary disease between 2018 and 2020. Ann Med. 2022;54(1):2181\u201390.","journal-title":"Ann Med"},{"key":"3399_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13113228","author":"A Herrera","year":"2024","unstructured":"Herrera A, Leiva L, Espinoza I, R\u00edos-Erazo M, Shakhtur N, Wurmann P, et al. Invisible, uncontrollable, unpredictable: illness experiences in women with Sj\u00f6gren syndrome. J Clin Med. 2024. https:\/\/doi.org\/10.3390\/jcm13113228.","journal-title":"J Clin Med"},{"issue":"2","key":"3399_CR30","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s40120-021-00285-w","volume":"10","author":"N Law","year":"2021","unstructured":"Law N, Davio K, Blunck M, Lobban D, Seddik K. The lived experience of Myasthenia Gravis: a patient-led analysis. Neurol Ther. 2021;10(2):1103\u201325.","journal-title":"Neurol Ther"},{"issue":"1","key":"3399_CR31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s12325-023-02704-w","volume":"41","author":"S Dewilde","year":"2024","unstructured":"Dewilde S, Phillips G, Paci S, De Ruyck F, Tollenaar NH, Janssen MF. The burden patients with myasthenia gravis experience in terms of breathing, fatigue, sleep, mental health, discomfort and usual activities in comparison to the general population. Adv Ther. 2024;41(1):271\u201391.","journal-title":"Adv Ther"},{"key":"3399_CR32","unstructured":"Janssen. Janssen Patient Engagement Research Councils. 2024. Available from: https:\/\/www.janssenpatientcouncils.com\/index.html"},{"issue":"2","key":"3399_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psychol"},{"issue":"1","key":"3399_CR34","doi-asserted-by":"publisher","first-page":"7271","DOI":"10.1038\/s41598-024-57825-1","volume":"14","author":"A Anderson","year":"2024","unstructured":"Anderson A, Pesa J, Choudhry Z, Brethenoux C, Furey P, Jackson L, et al. Patient perceptions of disease burden and treatment of myasthenia gravis based on sentiment analysis of digital conversations. Sci Rep. 2024;14(1):7271.","journal-title":"Sci Rep"},{"key":"3399_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12991-021-00372-0","volume":"20","author":"R Castilla-Puentes","year":"2021","unstructured":"Castilla-Puentes R, Dagar A, Villanueva D, Jimenez-Parrado L, Valleta LG, Falcone T. Digital conversations about depression among Hispanics and non-Hispanics in the US: a big-data, machine learning analysis identifies specific characteristics of depression narratives in Hispanics. Ann Gen Psychiatry. 2021;20:50.","journal-title":"Ann Gen Psychiatry"},{"issue":"6","key":"3399_CR36","doi-asserted-by":"publisher","DOI":"10.2196\/33637","volume":"6","author":"R Castilla-Puentes","year":"2022","unstructured":"Castilla-Puentes R, Pesa J, Brethenoux C, Furey P, Gil Valletta L, Falcone T. Applying the health belief model to characterize racial\/ethnic differences in digital conversations related to depression pre- and mid-COVID-19: descriptive analysis. JMIR Form Res. 2022;6(6):e33637.","journal-title":"JMIR Form Res"},{"key":"3399_CR37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s40120-022-00408-x","volume":"12","author":"K Jackson","year":"2022","unstructured":"Jackson K, Parthan A, Lauher-Charest M, Broderick L, Law N, Barnett C. Understanding the symptom burden and impact of myasthenia gravis from the patient\u2019s perspective: a qualitative study. Neurol Ther. 2022;12:107\u201328.","journal-title":"Neurol Ther"},{"key":"3399_CR38","doi-asserted-by":"publisher","first-page":"175628642211503","DOI":"10.1177\/17562864221150327","volume":"16","author":"M Mahic","year":"2023","unstructured":"Mahic M, Bozorg A, Rudnik J, Zaremba P, Scowcroft A. Healthcare resource use in myasthenia gravis: a US health claims analysis. Ther Adv Neurol Disord. 2023;16:17562864221150328.","journal-title":"Ther Adv Neurol Disord"},{"issue":"4","key":"3399_CR39","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s40120-022-00383-3","volume":"11","author":"M Mahic","year":"2022","unstructured":"Mahic M, Bozorg AM, DeCourcy JJ, Golden KJ, Gibson GA, Taylor CF, et al. Physician-reported perspectives on myasthenia gravis in the United States: a real-world survey. Neurol Ther. 2022;11(4):1535\u201351.","journal-title":"Neurol Ther"},{"issue":"02","key":"3399_CR40","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1017\/S0959259810000420","volume":"21","author":"G Windle","year":"2011","unstructured":"Windle G. What is resilience? A review and concept analysis. Rev Clin Gerontol. 2011;21(02):152\u201369.","journal-title":"Rev Clin Gerontol"},{"issue":"5","key":"3399_CR41","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S2215-0366(19)30434-1","volume":"7","author":"M Ungar","year":"2020","unstructured":"Ungar M, Theron L. Resilience and mental health: how multisystemic processes contribute to positive outcomes. Lancet Psychiatry. 2020;7(5):441\u20138.","journal-title":"Lancet Psychiatry"},{"issue":"9","key":"3399_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.70081","volume":"7","author":"M Yung","year":"2024","unstructured":"Yung M, Narayanaswami P, Pesa J, Choudhry Z, Jackson L, Deering KL, et al. Patient and care partner perspectives and preferences related to myasthenia gravis treatment: a qualitative study. Health Sci Rep. 2024;7(9):e70081.","journal-title":"Health Sci Rep"},{"issue":"1","key":"3399_CR43","doi-asserted-by":"publisher","first-page":"40","DOI":"10.21307\/ajon-2017-112","volume":"25","author":"T Keer-Keer","year":"2015","unstructured":"Keer-Keer T. The lived experience of adults with myasthenia gravis: a phenomenological study. Australas J Neurosci. 2015;25(1):40\u20136.","journal-title":"Australas J Neurosci"},{"key":"3399_CR44","first-page":"320","volume-title":"Social Epidemiology","author":"LD Kubzansky","year":"2014","unstructured":"Kubzansky LD. Affective States & Health. In: Berkman LF, Kawachi I, Glymour MM, editors. Social Epidemiology. New York, NY, USA: Oxford University Press; 2014. p. 320\u201364.","edition":"2"},{"key":"3399_CR45","doi-asserted-by":"publisher","first-page":"147997312311638","DOI":"10.1177\/14799731231163873","volume":"20","author":"D Zanolari","year":"2023","unstructured":"Zanolari D, H\u00e4ndler-Schuster D, Clarenbach C, Schmid-Mohler G. A qualitative study of the sources of chronic obstructive pulmonary disease-related emotional distress. Chron Respir Dis. 2023;20:14799731231163872.","journal-title":"Chron Respir Dis"},{"issue":"10","key":"3399_CR46","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.2337\/diacare.28.10.2378","volume":"28","author":"L Vileikyte","year":"2005","unstructured":"Vileikyte L, Leventhal H, Gonzalez JS, Peyrot M, Rubin RR, Ulbrecht JS, et al. Diabetic peripheral neuropathy and depressive symptoms: the association revisited. Diabetes Care. 2005;28(10):2378\u201383.","journal-title":"Diabetes Care"},{"key":"3399_CR47","doi-asserted-by":"publisher","first-page":"1309401","DOI":"10.3389\/fpubh.2024.1309401","volume":"12","author":"F Zhang","year":"2024","unstructured":"Zhang F, Yang W. Interaction between activities of daily living and cognitive function on risk of depression. Front Public Health. 2024;12:1309401.","journal-title":"Front Public Health"},{"key":"3399_CR48","doi-asserted-by":"publisher","DOI":"10.1177\/2333721417700011","volume":"3","author":"L Na","year":"2017","unstructured":"Na L, Streim JE. Psychosocial well-being associated with activity of daily living stages among community-dwelling older adults. Gerontol Geriatr Med. 2017;3:2333721417700011.","journal-title":"Gerontol Geriatr Med"},{"key":"3399_CR49","first-page":"234","volume-title":"Social Epidemiology","author":"LF Berkman","year":"2014","unstructured":"Berkman LF, Krishna A. Social network epidemiology. In: Berkman LF, Kawachi I, Glymour MM, editors. Social Epidemiology. New York, NY, USA: Oxford University Press; 2014. p. 234\u201389."},{"issue":"7","key":"3399_CR50","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1111\/jonm.13121","volume":"28","author":"LJ Labrague","year":"2020","unstructured":"Labrague LJ, De Los Santos JAA. COVID-19 anxiety among front-line nurses: predictive role of organisational support, personal resilience and social support. J Nurs Manag. 2020;28(7):1653\u201361.","journal-title":"J Nurs Manag"},{"issue":"10","key":"3399_CR51","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1037\/hea0000905","volume":"39","author":"BA Bryson","year":"2020","unstructured":"Bryson BA, Bogart KR. Social support, stress, and life satisfaction among adults with rare diseases. Health Psychol. 2020;39(10):912\u201320.","journal-title":"Health Psychol"},{"issue":"1","key":"3399_CR52","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12888-022-03985-1","volume":"22","author":"Y Tao","year":"2022","unstructured":"Tao Y, Yu H, Liu S, Wang C, Yan M, Sun L, et al. Hope and depression: the mediating role of social support and spiritual coping in advanced cancer patients. BMC Psychiatry. 2022;22(1):345.","journal-title":"BMC Psychiatry"},{"issue":"3","key":"3399_CR53","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s00415-009-5318-9","volume":"257","author":"M Dunand","year":"2010","unstructured":"Dunand M, Botez SA, Borruat FX, Roux-Lombard P, Spertini F, Kuntzer T. Unsatisfactory outcomes in myasthenia gravis: influence by care providers. J Neurol. 2010;257(3):338\u201343.","journal-title":"J Neurol"},{"issue":"4","key":"3399_CR54","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","volume":"87","author":"DB Sanders","year":"2016","unstructured":"Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, et al. International consensus guidance for management of myasthenia gravis: executive summary. Neurology. 2016;87(4):419\u201325.","journal-title":"Neurology"},{"issue":"6","key":"3399_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16265","volume":"31","author":"K \u00d8rstavik","year":"2024","unstructured":"\u00d8rstavik K, Rosenberger AD, Fossmo HL, Nordstr\u00f8m M, de Visser M. Multidisciplinary management and care in rare neuromuscular disorders: a call for action. Eur J Neurol. 2024;31(6):e16265.","journal-title":"Eur J Neurol"},{"issue":"5","key":"3399_CR56","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/mus.25725","volume":"56","author":"S Paganoni","year":"2017","unstructured":"Paganoni S, Nicholson K, Leigh F, Swoboda K, Chad D, Drake K, et al. Developing multidisciplinary clinics for neuromuscular care and research. Muscle Nerve. 2017;56(5):848\u201358.","journal-title":"Muscle Nerve"},{"key":"3399_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2021.07.396","author":"NE Gilhus","year":"2021","unstructured":"Gilhus NE, Verschuuren J, Hovland SIB, Simmonds H, Groot F, Palace J. Myasthenia gravis: do not forget the patient perspective. Neuromuscul Disord. 2021. https:\/\/doi.org\/10.1016\/j.nmd.2021.07.396.","journal-title":"Neuromuscul Disord"},{"issue":"21","key":"3399_CR58","doi-asserted-by":"publisher","first-page":"11591","DOI":"10.3390\/ijerph182111591","volume":"18","author":"AB Payedimarri","year":"2021","unstructured":"Payedimarri AB, Ratti M, Rescinito R, Vasile A, Seys D, Dumas H, et al. Development of a model care pathway for myasthenia gravis. Int J Environ Res Public Health. 2021;18(21):11591.","journal-title":"Int J Environ Res Public Health."},{"key":"3399_CR59","unstructured":"Myasthenia Gravis Foundation of America. Talking about MG. 2024. Available from: https:\/\/myasthenia.org\/living-with-mg\/after-your-diagnosis\/talking-about-mg\/"},{"key":"3399_CR60","unstructured":"Myasthenia-Gravis dot com (a Health Union community). Tips for talking to others about your myasthenia gravis. 2024. Available from: https:\/\/myasthenia-gravis.com\/talking-to-others"},{"key":"3399_CR61","unstructured":"Myasthenia-Gravis dot com (a Health Union community). Managing healthcare expenses. 2024. Available from: https:\/\/myasthenia-gravis.com\/resources-cost"},{"key":"3399_CR62","unstructured":"Myasthenia Gravis Foundation of America. Financial and support assistance. 2024. Available from: https:\/\/myasthenia.org\/Living-With-MG\/Educational-Resources-and-Assistance\/Financial-and-Support-Assistance\/"},{"issue":"8","key":"3399_CR63","doi-asserted-by":"publisher","DOI":"10.2196\/39172","volume":"24","author":"S Ashtari","year":"2022","unstructured":"Ashtari S, Taylor AD. The internet knows more than my physician: qualitative interview study of people with rare diseases and how they use online support groups. J Med Internet Res. 2022;24(8):e39172.","journal-title":"J Med Internet Res"},{"key":"3399_CR64","unstructured":"Myasthenia Gravis Foundation of America. MG friends program. 2024. Available from: https:\/\/myasthenia.org\/Living-With-MG\/Find-Support\/MG-Friends-Program\/"},{"key":"3399_CR65","unstructured":"Myasthenia Gravis Foundation of America. How to be an advocate for yourself and others with myasthenia gravis. 2023. Available from: https:\/\/myasthenia.org\/2023\/02\/28\/how-to-be-an-advocate-for-yourself-and-others-with-myasthenia-gravis\/"},{"issue":"1","key":"3399_CR66","doi-asserted-by":"publisher","DOI":"10.1080\/23311908.2015.1024928","volume":"2","author":"SF Cal","year":"2015","unstructured":"Cal SF, S\u00e1 LRd, Glustak ME, Santiago MB. Resilience in chronic diseases: a systematic review. Cogent Psychol. 2015;2(1):1024928.","journal-title":"Cogent Psychol"},{"issue":"4","key":"3399_CR67","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1177\/0145721707303809","volume":"33","author":"BG Bradshaw","year":"2007","unstructured":"Bradshaw BG, Richardson GE, Kumpfer K, Carlson J, Stanchfield J, Overall J, et al. Determining the efficacy of a resiliency training approach in adults with type 2 diabetes. Diabetes Educ. 2007;33(4):650\u20139.","journal-title":"Diabetes Educ"},{"issue":"1","key":"3399_CR68","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/sclerosis1010005","volume":"1","author":"KI Pakenham","year":"2023","unstructured":"Pakenham KI, Landi G. A pilot randomised control trial of an online acceptance and commitment therapy (ACT) resilience training program for people with multiple sclerosis. Sclerosis. 2023;1(1):27\u201350.","journal-title":"Sclerosis"},{"key":"3399_CR69","first-page":"512","volume-title":"Social Epidemiology","author":"LD Kubzansky","year":"2004","unstructured":"Kubzansky LD, Seeman TE, Glymour MM. Biological pathways linking social conditions and health: plausible mechanisms and emerging puzzles. In: Berkman LF, Kawachi I, Glymour MM, editors. Social Epidemiology. 2nd ed. New York, NY, USA: Oxford University Press; 2004. p. 512\u201361.","edition":"2"},{"key":"3399_CR70","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jad.2022.05.066","volume":"311","author":"W-W Rao","year":"2022","unstructured":"Rao W-W, Li M, Su Y, Caron J, Xiang Y-T, Meng X. How psychosocial stress profile influences the subsequent occurrence of neuropsychiatric comorbidities: a longitudinal population-based cohort study. J Affect Disord. 2022;311:294\u2013302.","journal-title":"J Affect Disord"},{"issue":"8","key":"3399_CR71","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/da.20571","volume":"26","author":"C Hammen","year":"2009","unstructured":"Hammen C, Kim EY, Eberhart NK, Brennan PA. Chronic and acute stress and the prediction of major depression in women. Depression Anxiety. 2009;26(8):718\u201323.","journal-title":"Depression Anxiety"},{"key":"3399_CR72","doi-asserted-by":"publisher","DOI":"10.12703\/r\/10-83","volume":"10","author":"BL Roberts","year":"2021","unstructured":"Roberts BL, Karatsoreos IN. Brain-body responses to chronic stress: a brief review. Fac Rev. 2021;10:83.","journal-title":"Fac Rev"},{"issue":"1","key":"3399_CR73","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000510696","volume":"90","author":"J Guidi","year":"2021","unstructured":"Guidi J, Lucente M, Sonino N, Fava GA. Allostatic load and its impact on health: a systematic review. Psychother Psychosom. 2021;90(1):11\u201327.","journal-title":"Psychother Psychosom"},{"key":"3399_CR74","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1146\/annurev-publhealth-012420-105104","volume":"43","author":"RC Shelton","year":"2022","unstructured":"Shelton RC, Philbin MM, Ramanadhan S. Qualitative research methods in chronic disease: introduction and opportunities to promote health equity. Annu Rev Public Health. 2022;43:37\u201357.","journal-title":"Annu Rev Public Health"},{"issue":"2","key":"3399_CR75","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1136\/ebmh.13.2.35","volume":"13","author":"S Peters","year":"2010","unstructured":"Peters S. Qualitative research methods in mental health. Evid Based Ment Health. 2010;13(2):35\u201340.","journal-title":"Evid Based Ment Health"},{"key":"3399_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1274688","volume":"11","author":"P Cimiano","year":"2024","unstructured":"Cimiano P, Collins B, De Vuono MC, Escudier T, Gottowik J, Hartung M, et al. Patient listening on social media for patient-focused drug development: a synthesis of considerations from patients, industry and regulators. Front Med Lausanne. 2024;11:1274688.","journal-title":"Front Med Lausanne"},{"issue":"5","key":"3399_CR77","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.drudis.2022.01.015","volume":"27","author":"AL Schmidt","year":"2022","unstructured":"Schmidt AL, Rodriguez-Esteban R, Gottowik J, Leddin M. Applications of quantitative social media listening to patient-centric drug development. Drug Discov Today. 2022;27(5):1523\u201330.","journal-title":"Drug Discov Today"},{"issue":"1","key":"3399_CR78","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12991-021-00372-0","volume":"20","author":"R Castilla-Puentes","year":"2021","unstructured":"Castilla-Puentes R, Dagar A, Villanueva D, Jimenez-Parrado L, Valleta LG, Falcone T. Digital conversations about depression among Hispanics and non-Hispanics in the USA: a big-data, machine learning analysis identifies specific characteristics of depression narratives in Hispanics. Ann Gen Psychiatry. 2021;20(1):50.","journal-title":"Ann Gen Psychiatry"},{"issue":"11","key":"3399_CR79","doi-asserted-by":"publisher","DOI":"10.2196\/14285","volume":"21","author":"A Booth","year":"2019","unstructured":"Booth A, Bell T, Halhol S, Pan S, Welch V, Merinopoulou E, et al. Using social media to uncover treatment experiences and decisions in patients with acute myeloid leukemia or myelodysplastic syndrome who are ineligible for intensive chemotherapy: patient-centric qualitative data analysis. J Med Internet Res. 2019;21(11):e14285.","journal-title":"J Med Internet Res"},{"issue":"3","key":"3399_CR80","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s40120-023-00472-x","volume":"12","author":"AA Tahami Monfared","year":"2023","unstructured":"Tahami Monfared AA, Stern Y, Doogan S, Irizarry M, Zhang Q. Understanding barriers along the patient journey in Alzheimer\u2019s disease using social media data. Neurol Ther. 2023;12(3):899\u2013918.","journal-title":"Neurol Ther"},{"issue":"1","key":"3399_CR81","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462323000399","volume":"39","author":"AP Holtorf","year":"2023","unstructured":"Holtorf AP, Danyliv A, Krause A, Hanna A, Venable Y, Mattingly TJ 2nd, et al. Ethical and legal considerations in social media research for health technology assessment: conclusions from a scoping review. Int J Technol Assess Health Care. 2023;39(1):e62.","journal-title":"Int J Technol Assess Health Care"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03399-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03399-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03399-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:05:27Z","timestamp":1763136327000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03399-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":81,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["3399"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03399-x","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Rachelle D. Rodriguez was an employee of Johnson & Johnson at the time of the study, and is currently consulting for Gilead Sciences through Biopoint and Star Epidemiology. Ashley E. L. Anderson has served on the speaker\u2019s bureau for Alexion Pharmaceuticals and has served on advisory boards and as a paid consultant for Johnson & Johnson. Kelly G. Gwathmey reports consulting for Argenx, UCB, and Alexion, and speaking engagements for Alexion. Caroline R. Brethenoux is an employee of Human Dot Plus, a research company paid by Johnson & Johnson to undertake the analyses for this study. Lisa M. Shea is an employee of Johnson & Johnson, and owns stock or stock options in Johnson & Johnson. Raghav Govindarajan has served on advisory boards for Argenx, UCB, Janssen, Roche, and speakers\u2019 bureaus for Argenx, Alexion, and UCB. Nizar Souayah reports having no conflicts to disclose. Wesley D. Peters is an employee of Evidera, which derives profits from interactions with pharmaceutical sponsors. Louis A. Jackson is an employee of Johnson & Johnson and owns stock or stock options in Johnson & Johnson. Zia U. Choudhry is an employee of Johnson & Johnson, and owns stock or stock options in Johnson & Johnson.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"A post hoc\/secondary qualitative analysis from transcripts of participants in focus groups were used for this study. Participants in the focus group were informed that participation was voluntary, that responses would be recorded, that no treatments would be provided, and that they could withdraw at any time. Participants signed a consent and release form that communicated confidentiality and Health Insurance Portability and Accountability Act (1996)-compliant practices. Data were anonymized. The original research was classified as market research, and therefore institutional review board approval was not needed. The focus group and analysis were conducted in accordance with the Helsinki Declaration of 1964 and its later amendments.For the digital conversation analysis, topic-specific data were collected from public domain sources only. These data were collected in an unidentified manner, and analysis was conducted on aggregated data only. No personal information, identifiers, or other identification-related information were collected. Data were stored on secure servers only while analysis was conducted and then purged per General Data Protection Regulation privacy guidelines. The study was therefore exempt from the need for institutional review board review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}